FRI0122 Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera from patients with rheumatoid arthritis

BackgroundMutated citrullinated vimentin (MCV) is one of the important targets of anti-citrullinated protein/peptide antibodies (ACPA) and is found in synovial fluid in patients with rheumatoid arthritis (RA). Serum anti-MCV antibody (anti-MCV) titer may be better correlated with RA disease activity